VKTX

Viking Therapeutics Stock Price

5.665
-0.105 (-1.82%)
Upgrade to Real-Time
Regular Market
5.665

Low
4.9508

52 Week Range

High
10.09

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.105 -1.82% 5.665 13:50:23
Open Price Low Price High Price Close Price Prev Close
5.815 5.61 5.815 5.77
Bid Price Ask Price Spread News
5.65 5.66 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,767 381,212 $ 5.69 $ 2,167,719 - 4.9508 - 10.09
Last Trade Time Type Quantity Stock Price Currency
13:51:41 5 $ 5.65 USD

Period:

Draw Mode:

Viking Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 442.44M 78.10M 66.41M $ - $ - -0.54 -9.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 20.00k 4.60%

more financials information »

Viking Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VKTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.796.0255.615.84538,466-0.125-2.16%
1 Month6.756.785.616.06678,378-1.09-16.07%
3 Months6.476.784.95085.90953,382-0.805-12.44%
6 Months7.2510.094.95086.721,142,547-1.59-21.86%
1 Year6.7710.094.95086.571,198,407-1.11-16.32%
3 Years10.8324.003.269.221,845,920-5.17-47.69%
5 Years1.3824.000.888.611,478,4764.29310.51%

Viking Therapeutics Description

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.


Your Recent History
NASDAQ
VKTX
Viking The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.